ATE354376T1 - Zusammensetzungen für die elektroporation - Google Patents

Zusammensetzungen für die elektroporation

Info

Publication number
ATE354376T1
ATE354376T1 AT00915386T AT00915386T ATE354376T1 AT E354376 T1 ATE354376 T1 AT E354376T1 AT 00915386 T AT00915386 T AT 00915386T AT 00915386 T AT00915386 T AT 00915386T AT E354376 T1 ATE354376 T1 AT E354376T1
Authority
AT
Austria
Prior art keywords
electroporation
compositions
drugs
percutaneous absorbability
elevating
Prior art date
Application number
AT00915386T
Other languages
English (en)
Inventor
Yoshihiro Tokudome
Koji Owaku
Kenichi Goto
Kenji Sugibayashi
Original Assignee
Pola Chem Ind Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pola Chem Ind Inc filed Critical Pola Chem Ind Inc
Application granted granted Critical
Publication of ATE354376T1 publication Critical patent/ATE354376T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT00915386T 1999-10-14 2000-04-06 Zusammensetzungen für die elektroporation ATE354376T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP29172199 1999-10-14

Publications (1)

Publication Number Publication Date
ATE354376T1 true ATE354376T1 (de) 2007-03-15

Family

ID=17772544

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00915386T ATE354376T1 (de) 1999-10-14 2000-04-06 Zusammensetzungen für die elektroporation

Country Status (8)

Country Link
US (1) US7089053B1 (de)
EP (1) EP1222932B1 (de)
JP (1) JP4868679B2 (de)
AT (1) ATE354376T1 (de)
AU (1) AU3671900A (de)
CA (1) CA2387953C (de)
DE (1) DE60033542T2 (de)
WO (1) WO2001026689A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4871469B2 (ja) * 1999-10-15 2012-02-08 ポーラ化成工業株式会社 エレクトロポーレーション用の経皮吸収促進剤
US8813221B1 (en) 2008-09-25 2014-08-19 Sonicwall, Inc. Reassembly-free deep packet inspection on multi-core hardware

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4933184A (en) 1983-12-22 1990-06-12 American Home Products Corp. (Del) Menthol enhancement of transdermal drug delivery
JPH02468A (ja) 1987-07-14 1990-01-05 Nisshin Flour Milling Co Ltd 乳酸桿菌に外来ｄｎａを導入する方法
WO1989006555A1 (en) * 1988-01-21 1989-07-27 Massachusetts Institute Of Technology Transport of molecules across tissue using electroporation
US5069908A (en) 1989-06-19 1991-12-03 Henley International, Inc. Crosslinked hydrogel and method for making same
GB8921710D0 (en) 1989-09-26 1989-11-08 Mentholatum Co Ltd Ibuprofen triturates and topical compositions containing same
AU7547891A (en) 1990-03-30 1991-10-30 Yasunori Morimoto Percutaneously absorbable composition of narcotic and nonnarcotic analgesics
US5176918A (en) * 1990-12-20 1993-01-05 Jones Jeffry L Topical medicament
JPH0616538A (ja) 1992-07-03 1994-01-25 Japan Tobacco Inc イオントフォレーゼのための薬物吸収用液組成物
US5997501A (en) 1993-11-18 1999-12-07 Elan Corporation, Plc Intradermal drug delivery device
AU2947795A (en) 1994-06-24 1996-01-19 Cygnus, Inc. Pulsatile delivery systems of biologically active agents using electro voltage pulsing for controlling membrane permeability
US6176842B1 (en) 1995-03-08 2001-01-23 Ekos Corporation Ultrasound assembly for use with light activated drugs
US5990179A (en) * 1995-04-28 1999-11-23 Alza Corporation Composition and method of enhancing electrotransport agent delivery
EP0747092B1 (de) 1995-06-09 2003-12-03 Hisamitsu Pharmaceutical Co., Inc. Matrix für Iontophorese
DE69629628T2 (de) 1995-06-14 2004-06-17 Hisamitsu Pharmaceutical Co., Inc., Tosu Schnittstelle für Iontophorese
JP3898250B2 (ja) * 1996-03-26 2007-03-28 久光製薬株式会社 エレクトロポレーション用マイクロエマルション製剤
ES2289192T3 (es) * 1996-12-31 2008-02-01 Altea Therapeutics Corporation Microporacion de tejido para suministro de agentes bioactivos.
US6228864B1 (en) * 1997-10-28 2001-05-08 Vivus, Inc. Administration of 5-HT receptor agonists and antagonists, to treat premature ejaculation
WO1999064615A1 (en) * 1998-06-08 1999-12-16 Valentis, Inc. Formulations for electroporation
AU4696499A (en) * 1998-06-19 2000-01-05 Genetronics, Inc. Electrically assisted transdermal method and apparatus for the treatment of erectile dysfunction
BR9914568A (pt) 1998-10-16 2001-07-03 Novo Nordisk As Formulação aquosa de insulina, preparação de insulina e método de tratamento de diabetes do tipo i ou do tipo ii
US6678558B1 (en) * 1999-03-25 2004-01-13 Genetronics, Inc. Method and apparatus for reducing electroporation-mediated muscle reaction and pain response

Also Published As

Publication number Publication date
WO2001026689A1 (fr) 2001-04-19
EP1222932A1 (de) 2002-07-17
DE60033542T2 (de) 2007-11-22
CA2387953C (en) 2008-12-09
JP4868679B2 (ja) 2012-02-01
CA2387953A1 (en) 2001-04-19
AU3671900A (en) 2001-04-23
EP1222932A4 (de) 2004-05-12
DE60033542D1 (de) 2007-04-05
US7089053B1 (en) 2006-08-08
EP1222932B1 (de) 2007-02-21

Similar Documents

Publication Publication Date Title
BG106440A (en) Nitrogen-heterocyclic derivatives as nos inhibitors
NO20062644L (no) DPP-IV inhibitorer
DE69803907D1 (de) Fungizide 2-Methoxybenzophenone
HK1089444A1 (en) Dihydropteridinones, method for the production and use thereof in the form of drugs
NO20054787L (no) Indenderivater som farmasotiske midler
ZA200309887B (en) Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents.
MX2007006397A (es) Derivados de tetrahidropirano.
PL368412A1 (en) Retinoid derivatives with antiangiogenic, antitumor and proapoptotic activities
ATE402173T1 (de) Stereoselektive synthese bestimmter trifluormethylsubstituierter alkohole
PL371127A1 (en) 6-aminomorphinane derivatives, method for the production and use thereof
SI1831239T1 (sl) Postopek za pripravo gamma laktona hidroksi beta beta beta beta bismetilen alfa pregn en on karboksilne kisline in ključniintermediati za ta postopek
UY26133A1 (es) Derivado sustituido de pirazol.
DE60031709D1 (de) Zusammensetzungen für die elektroporation
BRPI0108990B8 (pt) processo para preparação de derivados de pirimidona com atividade antifungos
WO2005009345A3 (en) 2-desmethyl ansamycin compounds
AU2003213661A8 (en) Amino-substituted sulfonanilides and derivatives thereof for treating proliferative disorders
DE60001366T2 (de) Orale zusammensetzung enthaltend perlit
DE60033542D1 (de) Zusammensetzungen für die elektroporation
ECSP034920A (es) Proceso para la preparacion de derivados de ciclohexanol
DE69706950D1 (de) Furoindolizine
GT200200250A (es) Compuestos hexaciclicos
ATE265418T1 (de) Neue substituierte 3-phenoxy- und 3- phenylalkyloxy-2-phenyl-propylamine
ATE328581T1 (de) Perkutane absorptionsbeschleuniger für die elektroporation
HN1999000157A (es) 1,2,3 tetrahidroquinolinas 2 - sustituidas 4 - amino sustituidas.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties